Latest ArticlesTo observe the effect of Yangyin Runfei Qingzao Decoction combined with pirfenidone on patients with idiopathic pulmonary interstitial fibrosis.
A total of 100 patients with idiopathic pulmonary fibrosis were selected from Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine in Hebei Province. They were enrolled from September 2020 to September 2023. They were grouped by random number table method. 50 patients in pirfenidone group (1 case dropped, 49 cases eventually included) were given pirfenidone capsule treatment, and 50 patients in the combined Chinese medicine group (1 case dropped, 1 case excluded, 48 cases eventually included) were given pirfenidone capsule treatment. The pirfenidone group was treated with Yangyin Runfei Qingzao Decoction at the same time. After treatment, the clinical efficacy of the two groups was compared, the 6 min walking distance (6MWT) was measured before and after treatment, and the patients were evaluated with St. George's Respiratory Questionnaire (SGRQ) and idiopathic pulmonary fibrosis Patient Quality of Life Scale (ATAQ-IPF). The levels of total lung volume (TLC), arterial oxygen saturation (SaO2), maximum mid-expiratory flow (MMF), and pulmonary carbon monoxide dispersion (DLco) were measured. Serum levels of IGFBP-5, CYFRA21-1, osteopontin, fibroblast growth factor (FGF -21), chemokine ligand 14 (CXCL14), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), CD4+and CD8+ were detected.
The total effective rate of Chinese medicine combined group was higher than that of pirfenidone group (P <0.05). The expression levels of 6MWT, SGRQ score, TLC, SaO2, FGF -21, MMF, GSH-Px, DLCO and CD4+ in Chinese medicine combined group were higher than those in pirfenidone group (P < 0.05). ATAQ-IPF score, CD8+, CXCL14, MDA, IGFBP-5, Cyfra21-1 and osteopontin expression in the Chinese medicine group were lower than those in pirfenidone group (P < 0.05).
The combination therapy of Yangyin Runfei Qingzao Decoction and pirfenidone in patients with idiopathic pulmonary fibrosis can reduce inflammation and oxidative injury, improve immune function, alleviate pulmonary fibrosis, and enhance patients' quality of life, exercise tolerance, and clinical efficacy.
To investigate the efficacy of modified Dingchuan Decoction in treating children with cough variant asthma (CVA) of phlegm-heat accumulation in the lung syndrome and its effects on eosinophil (EOS) and serum amyloid A (SAA) levels.
From June 2021 to June 2024, a total of 104 children diagnosed with CVA (Phlegm-Heat Accumulation in the Lung Syndrome) who received treatment at Huai'an Traditional Chinese Medicine Hospital were randomly assigned into two groups: an observation group comprising 52 cases and a control group also consisting of 52 cases, with the assignment process conducted using a random number table method. The control group received a therapeutic regimen consisting of budesonide suspension administered via inhalation, complemented by montelukast sodium chewable tablets taken orally, while the observation group was treated with modified Dingchuan Decoction. After 1 week of treatment, traditional Chinese medicine syndrome scores, inflammatory factors (EOS and SAA), immune indicators (CD3+, CD4+, and CD8+), pulmonary function indices (FEV1 and FVC), clinical efficacy, and adverse reactions were compared between the two groups.
After treatment, traditional Chinese medicine syndrome scores, EOS, SAA, and CD8+ levels in the observation group and the control group decreased, with the observation group showing lower levels than the control group (P < 0.05). The CD3+, CD4+, FEV1, and FVC levels in both groups increased compared to before treatment (P <0.05). The observation group had higher levels than the control group (P <0.05). The treatment efficacy rate in the observation group was higher than that in the control group (P <0.05). During the treatment, no severe adverse reactions were observed in either group.
The modified Dingchuan Decoction is effective in treating children with CVA, which helps to suppress airway inflammation and improve the anti asthmatic effect of children, with good safety.